Novartis Clinical Trials and Medical Research Studies Recruiting in the U.S.

Mailing List


	Sign up and receive information about Novartis clinical trials in your health-related areas of interest. For U.S. residents only.

Novartis Clinical Trials provides information about research studies recruiting within the U.S. Visit ClinicalTrials.gov, a registry of federally and privately supported clinical trial for more information regarding clinical trials outside of the U.S.

Clinical Trial and Medical Research Information

For Patients and Caregivers

Clinical trials are scientific and medical research studies designed to find better ways to treat or prevent diseases. The Novartis clinical trials website is designed to inform the public about important medical research studies as well as to educate patients and caregivers about the clinical trial process. To find out more about Novartis clinical trials currently enrolling in the U.S., please select a health condition below. Novartis recommends you consult with your physician before participating in a clinical trial.

Search for Clinical Trials by Health Condition

	Acute Myelogenous Leukemia (AML)
	Multiple Myeloma

	Oncology
	Psoriasis

Featured Novartis Clinical Trials

Psoriasis Study -A2303

This study will assess the safety and efficacy of an "investigational drug" compared to placebo and existing drug in patients that have moderate to severe, chronic, plaque-type psoriasis. An “investigational drug” is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA). This investigational drug may not become commercially available.

Psoriasis Study - A2304

This study will assess the safety and efficacy of two different doses and two different dose regimens of an "investigational drug" in patients that have moderate to severe, chronic, plaque-type psoriasis. An “investigational drug” is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA). This investigational drug may not become commercially available.

Multiple Myeloma (Refractory/Relapsed) Study - D2308

The purpose of this prospective, multinational, randomized, double-blind, placebo-controlled, parallel group Phase III study is to compare the results in progression-free survival of 2 combination therapies in people with previously treated multiple myeloma whose disease has recurred or progressed. An "investigational drug" is a drug that is being clinically tested and is not approved for sale or use in the United States by the Food and Drug Administration (FDA), for the indication in which it is being studied.

Pediatric Leukemia - A2114

Phase I/II, open-label, dose-escalating study to evaluate the safety, tolerability and pharmacokinetics of a twice daily investigational drug" and to evaluate the preliminary clinical and pharmacodynamic response when administered to pediatric patients ages 3 months to less than 18 years of age with one of the following relapsed or refractory leukemia's: 1. MLL (mixed-lineage-leukemia)-rearranged ALL (acute lymphocytic leukemia) patients 2. FLT3 (FMS-like tyrosine kinase receptor-3) mutated AML (acute myeloid leukemia) patients An “investigational drug” is a drug that is being tested and is not approved for sale in the United States by the U.S. Food and Drug Administration (FDA). This investigational drug may not become commercially available.

Additional Clinical Trial Information for Patients and Caregivers

ClinicalTrials.gov is a registry of federally and privately supported clinical trial and medical research studies conducted globally. The U.S. National Institutes of Health (NIH), through its National Library of Medicine (NLM), has developed this site in collaboration with the Food and Drug Administration (FDA), as a result of the FDA Modernization Act, passed into law in November 1997.

ClinicalTrials.gov provides the public with up-to-date information on clinical research. Each clinical trial listing will provide information about the trial's purpose, participation eligibility, and contact information.

	Site Map \| Contact Us \| Find a Clinical Trial \| Mailing List \| Clinical Trial FAQs
	Clinical Trials Glossary \| About Informed Consent \| Medical Research Areas
	Clinical Trial Resources \| How to use this website